Skip to main content
. 2022 Dec 22;9:1077271. doi: 10.3389/fnut.2022.1077271

TABLE 3.

Incidences of adverse effects.

Glucoraphanin group (n = 38) Placebo group (n = 38) P-value
Side effects 0 (0%) 0 (0%) N.A.
Adverse events 2 (5.3%) 8 (21.1%) 0.086

Data are shown as number (percentage).

P-values were determined using the chi-squared test.

N.A., not available.